Streetbeat News

Analyst Ratings

ZoomInfo Technologies (NASDAQ:ZI) has been analyzed by 14 financial analysts, showing a range of opinions. The average 12-month price target is now $20.14, down from $24.86, with high and low estimates of $24.00 and $16.00, respectively. Analysts have adjusted their ratings and price targets, with many lowering their expectations. ZoomInfo's revenue growth is strong at 9.11%, with a net margin of 9.62% and an ROE of 1.31%, but its ROA of 0.42% is below industry benchmarks. The company's debt-to-equity ratio is healthy at 0.59.

Portfolio Pulse from Benzinga Insights

January 02, 2024 | 9:00 pm

AVDX

GLBE

KVYO

MNDY

NCNO

SNOW

WDAY

WEAV

Piper Sandler analyst Brent A. Bracelin has made several rating changes for tech stocks, showing optimism for application software in 2024. NCNO and WEAV were upgraded to Overweight, AVDX was downgraded to Neutral, and U and BL were downgraded to Underweight. The analyst's top picks for 2024 include WDAY, SNOW, MNDY, KVYO, and GLBE, focusing on cloud recovery, data renaissance, and AI. WDAY, MNDY, and KVYO are highlighted for their value, while SNOW and GLBE are recommended for growth investors.

Portfolio Pulse from Anusuya Lahiri

January 02, 2024 | 8:36 pm

AAPL

ETSY

GOOG

NVDA

Gene Munster of Deepwater Asset Management predicts that smaller AI companies will outperform the 'Magnificent 7' mega-cap tech stocks in 2024. He recommends a 'dumbbell' investment approach, maintaining exposure to mega caps while investing in underappreciated AI stocks like Unity Software Inc (U) and Etsy Inc (ETSY). Munster suggests that Unity's work on spatial environments using AI and Etsy's implementation of AI in product development will benefit their stocks. He also favors Alphabet Inc (GOOG) and Apple Inc (AAPL) among the larger tech companies.

Portfolio Pulse from Adam Eckert

January 02, 2024 | 8:23 pm

VEEV

Analysts have published 18 ratings on Veeva Systems (NYSE:VEEV) in the last three months, with a diverse range of views. The average 12-month price target is $209.44, down 3.56% from the previous average. Analysts have made various adjustments to their ratings and price targets, with some raising and others lowering their expectations. Veeva is a leading provider of cloud-based software for the life sciences industry. Financial indicators show strong market presence, profitability, and financial management, with a market cap above industry average, positive revenue trend, high net margin, ROE, and ROA, and low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 02, 2024 | 8:01 pm

SLAB

Analysts have provided mixed reviews on Silicon Laboratories (NASDAQ:SLAB) over the past three months, with 6 ratings ranging from bullish to indifferent. The average 12-month price target is now $132.67, down from $153.20, with a high estimate of $170.00 and a low of $86.00. Analysts from firms like Stifel, JP Morgan, Morgan Stanley, and Keybanc have adjusted their ratings and price targets, reflecting changes in market conditions and company performance. Silicon Laboratories develops solutions for various markets and has a market cap below the industry average. It experienced a revenue decline of -24.48% as of September 30, 2023, but has strong net margin, ROE, and ROA figures, and a low debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 02, 2024 | 8:01 pm

PDD

PDD Holdings (NASDAQ:PDD) received 4 bullish analyst ratings in the latest quarter, with a 12-month average price target of $174.25, up from $145.50. Analysts from Benchmark and Goldman Sachs raised their price targets, reflecting positive sentiment based on the company's strong financial performance, including a 93.89% revenue growth rate, a 22.57% net margin, and an ROE of 10.11%. PDD Holdings operates a portfolio of businesses and aims to integrate more businesses into the digital economy.

Portfolio Pulse from Benzinga Insights

January 02, 2024 | 8:01 pm

VAC

Marriott Vacations (NYSE:VAC) received mixed analyst ratings in the latest quarter, with 5 analysts offering a range of views. The average 12-month price target is $104.6, with a high of $149.00 and a low of $65.00, reflecting a 24.2% decrease in the average target. Analysts from Jefferies, B of A Securities, Truist Securities, and JP Morgan have adjusted their ratings and price targets, indicating a shift in sentiment. Marriott Vacations operates in the leisure industry, primarily in the US, with challenges in revenue growth, net margin, ROE, ROA, and a conservative debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 02, 2024 | 8:01 pm

EXAS

Exact Sciences (NASDAQ:EXAS) has been rated by 5 analysts in the past three months, with 3 bullish and 2 somewhat bullish ratings. The average 12-month price target is $88.2, with a high of $91.00 and a low of $80.00, marking a 7.16% decrease in the average target. Analysts from Benchmark, Guggenheim, Goldman Sachs, and Piper Sandler have provided recent evaluations, with some lowering their price targets. Exact Sciences, known for its cancer screening tests, shows a positive revenue trend but lags in growth rate compared to peers, has a strong net margin, but faces challenges in ROE and excels in ROA. The company maintains a prudent debt management with a debt-to-equity ratio of 0.82.

Portfolio Pulse from Benzinga Insights

January 02, 2024 | 8:00 pm

ARWR

Arrowhead Pharma (NASDAQ:ARWR) has been analyzed by 4 analysts, showing a mix of bullish and indifferent sentiments. The average 12-month price target is $38.25, up from the previous $34.50. Analysts from B of A Securities and Morgan Stanley have adjusted their price targets, while RBC Capital maintains a high estimate. Arrowhead's financials indicate a market cap above industry average, a significant revenue decline, high net margin, and low ROE and ROA. The company has a conservative debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 02, 2024 | 8:00 pm

POWI

Stifel analyst Tore Svanberg has maintained a Buy rating on Power Integrations (NASDAQ:POWI) and increased the price target from $90 to $100, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 7:55 pm